Longbow Finance SA Invests $4.43 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Longbow Finance SA acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 8,490 shares of the medical equipment provider’s stock, valued at approximately $4,431,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical during the third quarter worth approximately $558,807,000. FMR LLC raised its holdings in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB raised its holdings in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Strategic Financial Concepts LLC raised its holdings in Intuitive Surgical by 50,740.8% during the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after purchasing an additional 312,056 shares in the last quarter. Finally, State Street Corp raised its holdings in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 6,240 shares of company stock worth $3,529,040. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Down 0.1 %

Shares of NASDAQ:ISRG opened at $591.01 on Tuesday. The stock has a market capitalization of $210.51 billion, a PE ratio of 92.20, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a fifty day moving average price of $566.43 and a 200 day moving average price of $526.49.

Wall Street Analyst Weigh In

Several research firms have issued reports on ISRG. Raymond James upped their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Finally, Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.